---
title: "Palisade Bio to meet investors at Leerink Partners Therapeutics Forum July 14-15"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292324391.md"
description: "Palisade Bio will hold investor meetings at the Leerink Partners Therapeutics Forum in Boston on July 14-15. Management plans to discuss its clinical development strategy, recent progress on lead candidate PALI-2108, and upcoming milestones for inflammatory bowel disease."
datetime: "2026-07-10T13:00:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292324391.md)
  - [en](https://longbridge.com/en/news/292324391.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292324391.md)
---

# Palisade Bio to meet investors at Leerink Partners Therapeutics Forum July 14-15

-   Palisade Bio flagged investor meetings at the Leerink Partners Therapeutics Forum in Boston on July 14-15. \* Management plans to discuss its clinical development strategy, recent progress on lead candidate PALI-2108, and upcoming inflammatory bowel disease milestones. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palisade Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607100900PRIMZONEFULLFEED9760277) on July 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [PALI.US](https://longbridge.com/en/quote/PALI.US.md)

## Related News & Research

- [Palisade Bio Q2 net loss widens on higher R&D costs](https://longbridge.com/en/news/295446808.md)
- [Palisade Bio Draws Bullish Call, Lead IBD Drug Advances Toward Phase 2](https://longbridge.com/en/news/293653896.md)
- [Scott Galloway says GLP-1 drugs are a 'silver bullet' for America's woes, if we're not 'stupid enough' to get in the way](https://longbridge.com/en/news/295999435.md)
- [Le Slip Francais reports 1,299,152 shares outstanding](https://longbridge.com/en/news/295558298.md)
- [07:20 ETAizen Enters into Collaboration with San Diego Biopharma to Advance Oral Biologics](https://longbridge.com/en/news/296000080.md)